Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells

(2011) Fernando Correa et al.   BRAIN BEHAVIOR AND IMMUNITY

Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor

(2011) D.M. Kerr et al.   NEUROSCIENCE

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

(2010) Gerty Schreibelt et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis

(2010) Silvia Rossi et al.   EXPERIMENTAL NEUROLOGY

Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance

(2010) Melissa Swiecki et al.   IMMUNOLOGICAL REVIEWS

The role of dendritic cells in CNS autoimmunity

(2010) Alla L. Zozulya et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism

(2010) Jason R Clapper et al.   NATURE NEUROSCIENCE

Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors

(2010) Maria Teresa Cencioni et al.   PLoS One

Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis

(2009) A. Bayas et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Characterization of the Endocannabinoid System in Human Neuronal Cells and Proteomic Analysis of Anandamide-induced Apoptosis

(2009) Nicoletta Pasquariello et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Role of the innate immune system in the pathogenesis of multiple sclerosis

(2009) Roopali Gandhi et al.   JOURNAL OF NEUROIMMUNOLOGY

Endocannabinoids and immune regulation☆

(2009) Rupal Pandey et al.   PHARMACOLOGICAL RESEARCH

The Endocannabinoid System and Multiple Sclerosis

(2008) David Baker et al.   CURRENT PHARMACEUTICAL DESIGN

The Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases

(2008) Diego Centonze et al.   CURRENT PHARMACEUTICAL DESIGN

Compromised CD4+ CD25highregulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level

(2007) Koen Venken et al.   IMMUNOLOGY